These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 22492235
1. Identification of functional elements of the GDP-fucose transporter SLC35C1 using a novel Chinese hamster ovary mutant. Zhang P, Haryadi R, Chan KF, Teo G, Goh J, Pereira NA, Feng H, Song Z. Glycobiology; 2012 Jul; 22(7):897-911. PubMed ID: 22492235 [Abstract] [Full Text] [Related]
2. CHO-gmt5, a novel CHO glycosylation mutant for producing afucosylated and asialylated recombinant antibodies. Haryadi R, Zhang P, Chan KF, Song Z. Bioengineered; 2013 Jul; 4(2):90-4. PubMed ID: 22989990 [Abstract] [Full Text] [Related]
3. Inactivation of GDP-fucose transporter gene (Slc35c1) in CHO cells by ZFNs, TALENs and CRISPR-Cas9 for production of fucose-free antibodies. Chan KF, Shahreel W, Wan C, Teo G, Hayati N, Tay SJ, Tong WH, Yang Y, Rudd PM, Zhang P, Song Z. Biotechnol J; 2016 Mar; 11(3):399-414. PubMed ID: 26471004 [Abstract] [Full Text] [Related]
4. Amino acid residues important for CMP-sialic acid recognition by the CMP-sialic acid transporter: analysis of the substrate specificity of UDP-galactose/CMP-sialic acid transporter chimeras. Takeshima-Futagami T, Sakaguchi M, Uehara E, Aoki K, Ishida N, Sanai Y, Sugahara Y, Kawakita M. Glycobiology; 2012 Dec; 22(12):1731-40. PubMed ID: 22833315 [Abstract] [Full Text] [Related]
5. Enhancing recombinant glycoprotein sialylation through CMP-sialic acid transporter over expression in Chinese hamster ovary cells. Wong NS, Yap MG, Wang DI. Biotechnol Bioeng; 2006 Apr 05; 93(5):1005-16. PubMed ID: 16432895 [Abstract] [Full Text] [Related]
6. Overexpression of UDP-GlcNAc transporter partially corrects galactosylation defect caused by UDP-Gal transporter mutation. Maszczak-Seneczko D, Olczak T, Jakimowicz P, Olczak M. FEBS Lett; 2011 Oct 03; 585(19):3090-4. PubMed ID: 21889501 [Abstract] [Full Text] [Related]
7. Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics. Kanda Y, Imai-Nishiya H, Kuni-Kamochi R, Mori K, Inoue M, Kitajima-Miyama K, Okazaki A, Iida S, Shitara K, Satoh M. J Biotechnol; 2007 Jun 30; 130(3):300-10. PubMed ID: 17559959 [Abstract] [Full Text] [Related]
8. Decrease in antithrombin III fucosylation by expressing GDP-fucose transporter siRNA in Chinese hamster ovary cells. Omasa T, Tanaka R, Doi T, Ando M, Kitamoto Y, Honda K, Kishimoto M, Ohtake H. J Biosci Bioeng; 2008 Aug 30; 106(2):168-73. PubMed ID: 18804060 [Abstract] [Full Text] [Related]
9. Incorporation of fucose into glycans independent of the GDP-fucose transporter SLC35C1 preferentially utilizes salvaged over de novo GDP-fucose. Skurska E, Szulc B, Maszczak-Seneczko D, Wiktor M, Wiertelak W, Makowiecka A, Olczak M. J Biol Chem; 2022 Aug 30; 298(8):102206. PubMed ID: 35772493 [Abstract] [Full Text] [Related]
10. In vivo evidence for GDP-fucose transport in the absence of transporter SLC35C1 and putative transporter SLC35C2. Lu L, Varshney S, Yuan Y, Wei HX, Tanwar A, Sundaram S, Nauman M, Haltiwanger RS, Stanley P. J Biol Chem; 2023 Dec 30; 299(12):105406. PubMed ID: 38270391 [Abstract] [Full Text] [Related]
11. Characterization of a mutation and an alternative splicing of UDP-galactose transporter in MDCK-RCAr cell line. Olczak M, Guillen E. Biochim Biophys Acta; 2006 Jan 30; 1763(1):82-92. PubMed ID: 16434112 [Abstract] [Full Text] [Related]
12. Slc35c2 promotes Notch1 fucosylation and is required for optimal Notch signaling in mammalian cells. Lu L, Hou X, Shi S, Körner C, Stanley P. J Biol Chem; 2010 Nov 12; 285(46):36245-54. PubMed ID: 20837470 [Abstract] [Full Text] [Related]
13. N-glycan structures and N-glycosylation sites of mouse soluble intercellular adhesion molecule-1 revealed by MALDI-TOF and FTICR mass spectrometry. Otto VI, Damoc E, Cueni LN, Schürpf T, Frei R, Ali S, Callewaert N, Moise A, Leary JA, Folkers G, Przybylski M. Glycobiology; 2006 Nov 12; 16(11):1033-44. PubMed ID: 16877748 [Abstract] [Full Text] [Related]
15. Mutations in the SLC35C1 gene, contributing to significant differences in fucosylation patterns, may underlie the diverse phenotypic manifestations observed in leukocyte adhesion deficiency type II patients. Skurska E, Szulc B, Kreczko K, Olczak M. Int J Biochem Cell Biol; 2024 Aug 12; 173():106602. PubMed ID: 38843991 [Abstract] [Full Text] [Related]
17. Functional expression of a human GDP-L-fucose transporter in Escherichia coli. Förster-Fromme K, Schneider S, Sprenger GA, Albermann C. Biotechnol Lett; 2017 Feb 12; 39(2):219-226. PubMed ID: 27738779 [Abstract] [Full Text] [Related]
18. Identification and characterization of human Golgi nucleotide sugar transporter SLC35D2, a novel member of the SLC35 nucleotide sugar transporter family. Ishida N, Kuba T, Aoki K, Miyatake S, Kawakita M, Sanai Y. Genomics; 2005 Jan 12; 85(1):106-16. PubMed ID: 15607426 [Abstract] [Full Text] [Related]
19. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. Wright A, Morrison SL. J Immunol; 1998 Apr 01; 160(7):3393-402. PubMed ID: 9531299 [Abstract] [Full Text] [Related]
20. Molecular analysis of three gain-of-function CHO mutants that add the bisecting GlcNAc to N-glycans. Stanley P, Sundaram S, Tang J, Shi S. Glycobiology; 2005 Jan 01; 15(1):43-53. PubMed ID: 15329358 [Abstract] [Full Text] [Related] Page: [Next] [New Search]